AAD 2026Abstract 72182
The impact of deucravacitinib on health-related quality of life and fatigue in patients with psoriatic arthritis
pooled analysis of phase 3 trials in patients with active psoriatic arthritis
Gottlieb AB, Mease PJ, Deodhar A, Perez-Chada LM, Armstrong AW, Eliason L, Roberts D, Plewinski M, Li J, Strand V
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: Psoriasis
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.1737 · Not in PubMed: details from Crossref